Zürcher Kantonalbank
-
Pharmaceutical giant ends nine year absence and takes Sfr2.2bn from its home market -
◆ Swiss bank introduces new bail-in structure ◆ ‘In-depth price discovery’ to reach final level ◆ Investors ‘get to grips’ with bail-in for issuer with no private shareholders
-
Swiss event marketing company raises Sfr77m to refinance a bond due 2023
-
The Swiss solar panel maker seeks to raise Sfr250m to expand production capacity
-
Attractive arbitrage on offer in Swiss francs for international funders
-
The Swiss corporate market has well and truly re-opened after the summer break, with the sector enjoying its busiest week since July
-
Swiss hospitals are increasingly looking to the local bond market to fund expansion
